Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
flu-neuraminidase
Press Release
Sep 19, 2017
InDevR Licenses Mount Sinai Influenza Antibodies for VaxArray® Neuraminidase Potency Assay
Panel of antibodies developed at Mount Sinai will enable first multiplexed potency assay for tracking neuraminidase in flu vaccines.
Read More
First
Prev
1
Next
Last
